Prof. Santos receives a prestigious European Research Council Proof of Concept Grant

This ERC PoC, iNANOVAC4CANCER, worth of 150 k€ for 18 months aims to develop biohybrid and biodegradable nanovaccines for cancer immunotherapy.

The main objective of iNANOVAC4CANCER is to establish technical and commercial viability for a personalized biohybrid and biodegradable nanovaccine platform, a novel patient-focused nanomaterial-based immunotherapy platform for the treatment of melanoma, prostate, and breast cancers with potential to expand to other cancers and diseases. 

Prof. Santos is among the 50 scientists who received an ERC PoC in the second round of 2018. See here for details

The ERC Proof of Concept funding is made available only to those who already have an ERC award to establish proof of concept of an idea that was generated in the course of their ERC-funded projects. For more details about ERC PoC in here

Prof. Santos was an ERC Starting Grant awardee in 2013-2017 with the project "Multistage-Multifunctional Porous Silicon Nanovectors for Directed Theranostics". For more details about the previous ERC StG of Prof. Santos in here

Other news about Prof. Santos' ERC PoC in e-journals (in Portuguese):

- ERC atribui subvenções de Prova de Conceito a quatro investigadores portugueses

- Quatro portugueses distinguidos entre 50 bolseiros do ERC pelo programa ‘Horizonte 2020’

- Quatro portugueses distinguidos por Bruxelas recebem 150 mil euros

- Quatro portugueses entre os 50 bolseiros distinguidos pelo programa de investigação da União Europeia

More about the subject: Health news